Unitree clears Shanghai IPO hurdle as China’s humanoid robot wave gathers pace
Unitree Robotics passed its Shanghai Star Market listing committee hearing, putting a 4.2 billion yuan IPO within reach as rival humanoid robot firms queue up behind it.
Unitree Robotics passed its Shanghai Star Market listing committee hearing, putting a 4.2 billion yuan IPO within reach as rival humanoid robot firms queue up behind it.
What just happened with Unitree's IPO?
Unitree Robotics, the Hangzhou-based humanoid robot maker, cleared its listing committee hearing on the Shanghai Star Market on June 1, 2026. The company had filed to list on March 20 and survived two rounds of regulatory inquiries plus an on-site inspection before reaching this point. The hearing approval moves the process into its final stages: registration and share issuance.
Unitree is seeking to raise 4.2 billion yuan (roughly US$621 million) by offering at least 40.4 million shares, which would represent a minimum 10 percent stake in the company. That valuation puts it among the larger tech listings on the Star Market in recent memory.
How does Unitree stack up against its competitors?
Unitree is not the only Chinese humanoid robot company racing toward a public listing, but its financials make it the one to watch. In 2025 the company posted 1.7 billion yuan in revenue, which placed it behind Hong Kong-listed UBTech's 2 billion yuan. On profitability, however, Unitree led the field: its net profit of 590.8 million yuan was the highest among its peers. That combination of scale and margin gives it a credible story to tell public market investors.
The broader queue is growing fast. Dobot, already listed in Hong Kong, is pursuing a dual listing on Shenzhen's ChiNext board. Leju Robotics and Deep Robotics are also advancing toward IPOs in Shenzhen and Shanghai respectively. The sector is moving from venture-backed startups to publicly traded companies in a compressed timeframe.
The humanoid IPO wave will raise market interest in robotics equities, said Zhong Sheng, head of China industrials research at Morgan Stanley.
Why does this matter for the robotics industry?
Unitree functions as a bellwether. Its listing will set a public market reference price for humanoid robotics valuations in China, giving investors a benchmark they currently lack. That matters because the companies behind it in the IPO queue will price their own offerings partly against whatever multiple Unitree achieves.
The IPO proceeds are also intended to fund investment in robot intelligence, what the company calls robot "brains." That signals where the competitive battle is heading: hardware margins are real, but the next round of differentiation will come from software and AI capabilities baked into the machines. Companies that can show a credible path to smarter robots will attract capital; those that cannot will struggle to justify their valuations once the initial excitement fades.
What happens next?
With the listing committee hearing cleared, Unitree must now complete registration with Chinese securities regulators before it can issue shares. That step typically takes weeks to a few months depending on regulatory workload and market conditions. Once Unitree trades, the performance of its stock will shape how quickly and at what terms its competitors can complete their own listings. A strong debut accelerates the whole sector; a weak one could prompt investors to scrutinize the others more carefully.
For international observers, the cluster of Chinese humanoid robot IPOs arriving in 2026 represents a structural shift. These companies are no longer just competing on factory floors or at trade shows. They are competing for capital allocation decisions made by fund managers in Shanghai, Hong Kong, and beyond.
How much money is Unitree trying to raise in its IPO, and what will it be used for?
Unitree is seeking to raise 4.2 billion yuan (about US$621 million) by selling at least 40.4 million shares, representing a minimum 10 percent stake. The company has indicated the funds will go toward investing in robot intelligence capabilities, essentially the AI and software that controls its humanoid machines.
How does Unitree's IPO affect the valuation of other Chinese humanoid robot companies?
Unitree will establish the first major public market reference point for humanoid robotics valuations in China. Competitors including Dobot, Leju Robotics, and Deep Robotics are all pursuing their own listings, and the price-to-earnings or price-to-revenue multiple that Unitree achieves will directly influence how those companies are priced when they come to market.
What regulatory steps remain before Unitree can actually begin trading?
Clearing the listing committee hearing is not the final step. Unitree still needs to complete registration with Chinese securities regulators before it can issue shares and begin trading on the Shanghai Star Market. That process typically takes several weeks to a few months.